For People with Genetic Risk Factors
Real-time molecular context alongside genetic testing.
If you know you carry a hereditary mutation (such as Lynch syndrome, or others), you already understand the importance of vigilance. Genetic predisposition highlights possibility but it does not provide information about what’s happening in your body right now.
The miRoncol Real-time Multi-Cancer Early Risk Assessment adds a real-time biological layer to your preventive strategy, giving you and your physician more context for monitoring and follow-up.
Why It Matters
- Genetic testing reveals inherited predisposition, which is important for long-term risk management.
- However, most cancers arise from a mix of genetics, environment, and lifestyle not mutations alone.
- Real-time molecular signals, like microRNA changes in blood, may appear before imaging or symptoms, offering additional insight.
How the Test Helps
The miRoncol test evaluates microRNA signatures linked to common solid tumours, providing:
- Current molecular risk signals that complement hereditary risk knowledge
- Coverage of more than a dozen cancers, including, colorectal, ovarian, prostate, and others relevant to hereditary syndromes
- Support for physician conversations when planning timing of surveillance or further investigations
Benefits for People with Genetic Risk
- Complements genetic counselling and surveillance imaging
- Provides real-time context beyond static hereditary information
- Can be repeated regularly for ongoing monitoring
- Supports personalized prevention strategies
Limitations & Ethics
This test is not a replacement for genetic counselling or physician-recommended surveillance. Instead, it provides additional real-time biological context that may help guide discussions and follow-up planning.
Next Step
For patients with known genetic risk factors, knowledge is power but so is current biological insight. miRoncol helps bridge the gap by showing what’s happening in your body today.
How It Fits Into Preventive Care
- Use alongside recommended clinical screening (e.g., colonoscopy, mammography, MRI, or others advised by your physician)
- Incorporate into executive health or integrative medicine programs
- Provides an extra layer of molecular monitoring between traditional screening intervals
